Juan-Carlos Garcia-Pagan Selected Research

Juan-Carlos Garcia-Pagan Research Topics

6	Hemorrhage 01/2023 - 07/2009
6	Thrombosis (Thrombus) 01/2022 - 01/2010
3	Portal Hypertension 01/2022 - 06/2006
2	Hepatic Encephalopathy 01/2023 - 06/2013
2	Fibrosis (Cirrhosis) 01/2023 - 10/2018
2	Inflammation (Inflammations) 01/2022 - 02/2016
2	Ascites 01/2019 - 01/2010
2	Idiopathic Noncirrhotic Portal Hypertension 01/2019 - 07/2009
1	Disease Progression 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2021
1	Liver Diseases (Liver Disease) 10/2018
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 11/2017
1	Liver Failure 02/2016
1	Neoplasms (Cancer) 08/2009
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 08/2009
1	Heart Failure 08/2009
1	HIV Infections (HIV Infection) 07/2009

4	AnticoagulantsIBA 01/2023 - 01/2021
2	CalreticulinIBA 11/2017 - 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	von Willebrand FactorIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 07/2021
1	CreatinineIBA 01/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2016
1	salicylhydroxamic acid (SHAM)IBA 06/2006
1	Propranolol (Inderal)FDA LinkGeneric 06/2006

7	Therapeutics 01/2023 - 07/2009
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023 - 06/2013
1	Contraindications 01/2023
1	Transjugular Intrahepatic Portasystemic Shunt 01/2023
1	Splenectomy 01/2019
1	Warm Ischemia 02/2016
1	Liver Transplantation 08/2009
1	Highly Active Antiretroviral Therapy (HAART) 07/2009